Hydroxyurea Articles
Senicapoc could benefit SCD patients
11 February 2008
AOP Orphan gains EU OK for Thromboreductin
26 July 2004
Shire's profits up on switching strategy
3 March 2003
Shire files Xagrid for European approval
8 April 2002
SuperGen's sickle cell drug shows promise
6 November 2000
HIV/AIDS therapy sales forecasts to 2009
3 August 2000
B-MS South Africa deal for AIDS program
7 September 1999
Oral PMPA Enters Phase II
10 September 1998
More Competition In Hydroxyurea Market
6 August 1998
B-MS' Droxia OKed For Sickle Cell
5 March 1998
A Real Challenge To HIV With New Therapies?
12 February 1998
B-MS Receives Droxia OK From FDA Panel
2 January 1998
Cypros Progress With Sickle Cell Drug
6 November 1997
HIV News In Brief: Research And Trials
20 October 1997
Hydroxyurea Enhances Didanosine Effects
29 July 1996
B-MS' Hydroxyurea Effective In Sickle Cell
13 February 1995
Hydroxyurea And HIV
14 November 1994
EXPANDING USES FOR INTERFERON ALPHA
31 May 1993
WORLD PRODUCT NEWS IN BRIEF
18 January 1993
JAPANESE DRUG APPROVALS
22 June 1992
TRIAL RESULTS WITH ROBERTS' AGRELIN
27 January 1992
Showing 1-26 of 26 articles
- 1
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
